FDA clears at-home risankizumab induction

• by Teraya Smith

• October 23, 2026

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

• by Kathryn Wighton

• August 28, 2026

• 2 min

Emergency diagnosis may flag poor outcomes beyond cancer

Across 13 noncancer conditions, emergency diagnosis was common and associated with higher 1-year mortality.

• by Andrea Surnit

• August 31, 2026

• 4 min

Misleading AI summaries may alter recall

Participants exposed to inaccurate postevent summaries were less likely to correctly remember key details from videos they had previously watched.

• by Andrea Surnit

• September 30, 2026

• 3 min